National Stroke Association

Closed

And what is more important, according to the National Stroke Association, the second strokes are fatal in 25% of cases, and often lead to a disability worse and are more expensive to treat than the first stroke. Studies have shown that in the 5 years following a stroke, 24% of women and 42% of men have another. Now a new study called the progress study has revealed that more than 500,000 of these incidents a year could be prevented using a combination of Aceon or perindopril and indapamide (a diuretic). Surprisingly, recent clinical trials showed that using Aceon or perindopril, in combination with a diuretic, reduces the risk of a second stroke up to 50%. There was a 38% reduction in fatal stroke in patients using therapy based on perindopril and a reduction of 50% in dementia and cognitive impairment would be associated with stroke for patients of mini strokes that have experienced a recurrent stroke. The study showed that even patients with a normal blood pressure would benefit from this therapy. While a stroke is difficult for the body, suffering a second stroke is devastating. Now this study gives hope for the thousands of stroke survivors at risk for another.

The study examined 6,000 patients in the first test at random using an ACE inhibitor or a combination ACE inhibitor and diuretic, and was carried out in 10 countries during the past five years. Aceon is currently approved by the Food and Drug Administration (FDA) for use as antihypertensive or blood pressure reducer. It is classified as an inhibitor of the enzyme angiotensin-converting enzyme (ACE), which maintains the elasticity of the walls of the blood vessels, protecting them from damage and reducing the possibility of blood clots or hemorrhages. Given that with age, the blood vessels become less elastic and can lead to high blood pressure, Aceon helps to relax blood vessels and allow one gradual decrease of the blood pressure, which can prevent a stroke. A great advantage of Aceon is that it is a daily medication of a dose with efficacy of 24 hours. While aspirin is now the treatment of gold standard for many patients of apoplexy by its cost and efficiency, the results of therapy with perindopril demonstrate new options to seriously reduce the harmful effects of a stroke, including dementia and brain function. The usual starting dose of Aceon is 4 mg daily, taken as a single dose or divided into two smaller doses, and your doctor may increase the dose until your blood pressure is under control, up to a maximum of 16 mg per day. Aceon side effects are rare and light, and usually appear at the beginning of the treatment. Cough, fatigue, weakness, headache, changes of mood and/or sleep have been described, and less often, alterations of taste, epigastric pain, nausea, abdominal pain and rashes.

This entry is filed under News. You can follow any responses to this entry through RSS 2.0. Both comments and pings are currently closed.

Comments are currently closed.




© 2012-2018 Artieda 2011 All Rights Reserved